Publications by authors named "Colombe Chappey"

Claim this Profile
F
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study.
Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Colombe Chappey

Cancer Res Commun· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors: The JAVELIN PARP Medley Nonrandomized Controlled Trial.
Timothy A Yap, Aditya Bardia, Michael Dvorkin, Matthew D Galsky, J Thaddeus Beck, Colombe Chappey

JAMA Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial.
Alison M Schram, Nicoletta Colombo, Edward Arrowsmith, Vivek Narayan, Kan Yonemori, Colombe Chappey

JAMA Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline Mutations (ABRAZO).
Nicholas C Turner, Melinda L Telli, Hope S Rugo, Audrey Mailliez, Johannes Ettl, Colombe Chappey

Clin Cancer Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, virology and pharmacokinetics of oseltamivir in infants with laboratory-confirmed influenza: a Phase I/II, prospective, open-label, multicentre clinical trial.
Barbara A Rath, Jerzy Brzostek, Sara Guillén, Vis Niranjan, Colombe Chappey

Antivir Ther· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and pharmacokinetics of intravenous oseltamivir: single- and multiple-dose phase I studies with healthy volunteers.
Barbara J Brennan, Brian Davies, Georgina Cirrincione-Dall, Peter N Morcos, Anna Beryozkina, Colombe Chappey

Antimicrob Agents Chemother· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase.
Trevor Hinkley, João Martins, Colombe Chappey, Mojgan Haddad, Eric Stawiski

Nat Genet· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in reversion of resistance mutations to wild-type under structured treatment interruption and related increase in replication capacity.
Agnes C Paquet, John Baxter, Jodi Weidler, Yolanda Lie, Jody Lawrence, Colombe Chappey

PLoS One· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of standard PCR/cloning to single genome sequencing for analysis of HIV-1 populations.
Michael R Jordan, Mary Kearney, Sarah Palmer, Wei Shao, Frank Maldarelli, Colombe Chappey

J Virol Methods· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Principal component analysis of general patterns of HIV-1 replicative fitness in different drug environments.
João Z R Martins, Colombe Chappey, Mojgan Haddad, Jeannette M Whitcomb, Eric Stawiski

Epidemics· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistance.
Madhavi Kolli, Eric Stawiski, Colombe Chappey, Celia A Schiffer

J Virol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1.
Sergei L Kosakovsky Pond, David Posada, Eric Stawiski, Colombe Chappey, Art F Y Poon

PLoS Comput Biol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda.
Susan H Eshleman, Oliver Laeyendecker, Neil Parkin, Wei Huang, Colombe Chappey

AIDS· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitation of HER2 expression or HER2:HER2 dimers and differential survival in a cohort of metastatic breast cancer patients carefully selected for trastuzumab treatment primarily by FISH.
Christine Desmedt, Jeff Sperinde, Fanny Piette, Weidong Huang, Xueguang Jin, Colombe Chappey

Diagn Mol Pathol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, genotypic associations and phenotypic characterization of K65R, L74V and other HIV-1 RT resistance mutations in a commercial database.
Damian J McColl, Colombe Chappey, Neil T Parkin, Michael D Miller

Antivir Ther· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an HIV-1 reference panel of subtype B envelope clones isolated from the plasma of recently infected individuals.
Becky Schweighardt, Yang Liu, Wei Huang, Colombe Chappey, Yolanda S Lie

J Acquir Immune Defic Syndr· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism.
Jeannette M Whitcomb, Wei Huang, Signe Fransen, Kay Limoli, Jonathan Toma, Colombe Chappey

Antimicrob Agents Chemother· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infection.
Philippe Flandre, Colombe Chappey, Anne Genevieve Marcelin, Kirk Ryan, Jen-Fue Maa

J Infect Dis· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism.
Monique Nijhuis, Noortje M van Maarseveen, Stephane Lastere, Pauline Schipper, Eoin Coakley, Colombe Chappey

PLoS Med· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential impact of thymidine analogue mutations on emtricitabine and lamivudine susceptibility.
Lisa L Ross, Neil Parkin, Peter Gerondelis, Colombe Chappey, Mark R Underwood

J Acquir Immune Defic Syndr· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus.
Rika Draenert, Todd M Allen, Yang Liu, Terri Wrin, Colombe Chappey

J Exp Med· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The K101P and K103R/V179D mutations in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nonnucleoside reverse transcriptase inhibitors.
Neil T Parkin, Soumi Gupta, Colombe Chappey, Christos J Petropoulos

Antimicrob Agents Chemother· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection.
Simon D W Frost, Terri Wrin, Davey M Smith, Sergei L Kosakovsky Pond, Yang Liu, Colombe Chappey

Proc Natl Acad Sci U S A· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B.
Simon D W Frost, Yang Liu, Sergei L Kosakovsky Pond, Colombe Chappey, Terri Wrin

J Virol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for positive epistasis in HIV-1.
Sebastian Bonhoeffer, Colombe Chappey, Neil T Parkin, Jeanette M Whitcomb, Christos J Petropoulos

Science· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis